| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VGLL1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | PRPF40A | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | VPREB3 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | C4orf47 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | TAX1BP3 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | FAM118A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | POLR2M | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | SEL1L2 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | G0S2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | TRIM67 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
